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Abstract
Cell cycle transitions spanning meiotic maturation of the Xenopus oocyte and early embryo-
genesis are tightly regulated at the level of stored inactive maternal mRNA.We investigated
here the translational control of cyclin E1, required for metaphase II arrest of the unfertilised
egg and the initiation of S phase in the early embryo. We show that the cyclin E1 mRNA is reg-
ulated by both cytoplasmic polyadenylation elements (CPEs) and two miR-15/16 target sites
within its 3’UTR. Moreover, we provide evidence that maternal miR-15/16microRNAs co-
immunoprecipitate with CPE-binding protein (CPEB), and that CPEB interacts with the RISC
component Ago2. Experiments using competitor RNA andmutated cyclin E1 3’UTRs suggest
cooperation of the regulatory elements to sustain repression of the cyclin E1mRNA during
early stages of maturation when CPEB becomes limiting and cytoplasmic polyadenylation of
repressed mRNAs begins. Importantly, injection of anti-miR-15/16 LNA results in the early
polyadenylation of endogenous cyclin E1mRNA during meiotic maturation, and an accelera-
tion of GVBD, altogether strongly suggesting that the proximal CPEB andmiRNP complexes
act to mutually stabilise each other. We conclude that miR-15/16 and CPEB co-regulate cyclin
E1mRNA. This is the first demonstration of the co-operation of these two pathways.
Introduction
Regulation of gene expression at the level of translation is pivotal in early development, particularly
during meiotic maturation of the oocyte and early embryogenesis, when transcription is shut
down. During these periods, stored maternal mRNA, held in a translationally quiescent state in the
oocyte, is mobilised into polysomes to provide the egg and embryo with critical cell cycle regulatory
factors. The targets, as well as the cis- and trans-acting players involved in such control mecha-
nisms, have been especially well-studied in Xenopus laevis. Xenopus (stage VI) oocytes, arrested in
prophase of meiosis I, can be triggered to undergomeiotic maturation (GVBD or germinal vesicle
breakdown) with progesterone, and laid eggs can be readily fertilised to generate embryos, which
only initiate zygotic transcription after the 12th cell division (mid-blastula transition).
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Work in several laboratories has shown that a major regulator of translation in Xenopus
oocytes and eggs is CPEB, which mediates both translational repression in the oocytes and sub-
sequently translational activation in the egg [1, 2]. CPEB, an RRM and Zinc finger-containing
protein, interacts with short U-rich elements, called cytoplasmic polyadenylation elements
(CPEs), typically U4AU, in the 3‘UTR of regulated mRNAs such as those encoding cyclin B1
and c-mos. Binding of CPEB to CPEs in target mRNAs in oocytes results in the formation of a
repressed closed-loop of mRNA, with the cap-binding eIF4E protein prevented from productive
interaction with eIF4G to recruit the small ribosomal subunit to initiate translation. eIF4E-bind-
ing factors, which interact directly or indirectly with CPEB to form this loop have been character-
ised, including 4E-T (reviewed [3]). Meiotic maturation results in CPEB phosphorylation leading
eventually to its proteolysis shortly after GVBD. Prior to GVBD, CPEB phosphorylation is pro-
posed to both allow release of co-repressors and the stable association with the GLD-2 poly(A)
polymerase to promote cytoplasmic polyadenylation of the repressed mRNAs, resulting in effi-
cient translation [4–11]. Additional 3’UTR-binding protein factors, including Musashi and
Pumilio, co-regulate mRNA poly(A) tail lengths and translation with CPEB in meiosis [11, 12].
Regulation of gene expression by polyadenylation in Xenopus eggs is enabled by the absence of
decapping activity in early development till the mid-blastula transition, ensuring the stability of
maternal mRNAs with short poly(A) tails for months in the ovary [13, 14]. In contrast, in
somatic cells, such mRNAs would rapidly undergo decapping, and then decay [15].
miRNAs, short ~22 nt non-coding RNAs that are processed from longer hairpin-containing
transcripts by Drosha and Dicer nucleases, bind to mRNA typically in their 3’UTR, and also
regulate translation and/or mRNA decay. Complementarity to the 50 end of the miRNA—the
'seed' sequence, containing nucleotides 2–7—is a major determinant in target recognition and
is sufficient to trigger silencing. microRNA silencing of target mRNAs is mediated by the mul-
tiprotein complex miRNP/miRISC, which includes the key protein components Argonaute 2
and GW182 (TNRC6A-C in humans) (reviewed [16, 17]). According to several recent studies,
microRNAs first mediate translational repression, at the level of initiation, and subsequently
lead to deadenylation and decay of their target mRNAs [18–21].
Previously, we and others have identified microRNAs in Xenopus laevis and tropicalis
oocytes by high-throughput sequencing, and verified their presence by Northern blot analysis
[22–24]. MicroRNAs have also been identified in mouse oocytes, and initial studies showed
that mouse Dicer -/- oocytes fail to make the meiosis I-II transition and to progress through
the first cell division, suggesting an important early developmental role for maternal micro-
RNAs [25, 26]. In contrast, more recent reports suggest that miRNA function is suppressed in
murine oocytes [27, 28]. Of note, however, mouse oocytes undergo meiosis I (~10–17 days) in
considerably less time than in Xenopus (~ 3–5 months), and mouse maternal mRNAs are
degraded and replaced by zygotic transcripts at the 2 cell stage, rather that at the12th cell divi-
sion as in Xenopus embryogenesis, (reviewed [29, 30], implying that regulation of maternal
mRNA translation may not be as important in early mouse development as it is in Xenopus.
Here we focus on miR-15/16, abundant/moderately abundant microRNAs in Xenopus
oocytes and eggs [22–24]. miR-15 and miR-16 are present in gene clusters and share the same
8 nt seed sequence. The highly-conserved mir-15/16 cluster is frequently deleted in cancer, and
in mammalian cell lines silencing by miR-15/16 induces cell cycle arrest in G1/G0. Overexpres-
sion of these miRNAs inhibits cell proliferation, promotes apoptosis of cancer cells, and sup-
presses tumorigenicity both in vitro and in vivo (reviewed [31, 32]). In other words, miR-15/16
can act as tumor suppressors.
One of the major targets of miR-15/16 in mammalian cells is cyclin E1 mRNA, with two
conserved 3’UTR binding sites [33–36]. Interestingly, work in Xenopus oocytes, eggs and
embryos suggested that cyclin E1 mRNA may be translationally regulated during meiosis [37–
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39]. Cyclin E1/Cdk2 is required for metaphase II arrest of the unfertilised egg as well as initia-
tion of the S phase in the early embryo [40, 41].
We investigated maternal cyclin E1 mRNA expression, which we demonstrate to be regulated at
the level of translation by repression in the oocyte, and cytoplasmic polyadenylation in the egg,
mediated both by CPE elements and by miR-15/16 binding sites in its 3’UTR. In line with these
reporter studies, mature forms of maternal miR-15/16 were shown to co-immunoprecipitate specif-
ically with the CPEB complex. Sequestering of CPEB protein by pre-injected short CPE-containing
RNA reduces miR-mediated repression of reporter mRNA in the oocyte. Strikingly, injection of
anti-miR-15/16 LNA results in the early polyadenylation of endogenous cyclin E1 mRNA during
meiotic maturation, and an acceleration of GVBD, altogether suggesting the co-occupancy of the
CPEB and miRNP/RISC complexes on the mRNA reinforces their activity. Thus, we provide the
first evidence of cooperative activity of these two important post-transcriptional pathways.
Materials and Methods
All experiments involving Xenopus laevis were performed in accordance with the Animals (Sci-
entific Procedures) Act 1986 under Schedule 1. Specific details: University of Cambridge commit-
tee approval—by AWERB (Animal Welfare & Ethical Review Body) All animals purpose bred
for research from commercial sources. Animals are sacrificed using a Home Office approved
Schedule 1 method which is a non licensed method. Method, Overdose of anaesthetic by immer-
sion in MS222 for 30 min, followed by destruction of the brain to confirm death. The University
Animal Welfare Policy (available on request) details that Animals are transported, housed and
cared for by dedicated and trained staff under professional supervision in a manner designed to
ensure the best health and well-being of the animal, with provisions for environmental enrich-
ment. Named Veterinary Surgeons are available at all times for consultation, care and attendance.
The University of Cambridge is committed to the responsible use of animals in its research and
teaching activities. All University personnel who supervise or undertake activities involving ani-
mals are trained to carry out their duties in a responsible and humane manner.
Plasmid constructs and in vitro transcription
The plasmids encoding the tethering constructs HA-GW182-ED, NHA-GW-182-ED, Rluc-BoxB
used were a kind gift ofW. Filipowicz [42]. For in vitro transcriptions, plasmids encoding the HA-
tagged proteins or the Rluc-BoxB were linearised withNot I or BamH I, respectively, prior to tran-
scription with T7 RNA polymerase. TheXenopus tropicalisAgo2ORF (NM_001004877) was cloned
into pCS2 vector containing an HA tag at the C-terminal end.Hpa I linearisation of the pCS2-HAx-
tAgo2 plasmid was followed by SP6 in vitro transcription (AmbionmMessage mMachine kit) and
addition of poly(A) tail (Ambion Poly(A) Tailing kit) according to the manufacturer’s instructions.
The pIRESneo-FLAG/HA_Ago2_corrected plasmid (Addgene) encoding human Ago2 was linear-
ised with BamH I, followed by T7 transcription (AmbionmMessage mMachine kit) and addition of
poly(A) tail (Ambion Poly(A) Tailing kit) according to the manufacturer’s instructions.
The cyclin E1 3’UTR was amplified by PCR using primers JA17/18 from the pBluescript
plasmid template (a gift from Anne Couturier; [38]) and cloned into firefly Luc-MCS [43]
digested with Sac I and Kpn I, producing Luc-MCS cycE1 WT. To obtain a construct contain-
ing mutations in all CPE sequences within the cyclin E1 3’UTR (CPE mut), the LUC-MCS
cycE1 plasmid was subjected to sequential QuikChange site-directed mutagenesis (Stratagene)
with the following primer pairs: JA21/22, JA23/24, JA 25/26, JA29/30 (For oligonucleotide
primer sequences see S1 Table). Site-directed mutagenesis using primer pairs miR-16-1 mut
for/miR-16-1 mut rev and miR-16-2 mut for/miR-16-2 mut rev was used to introduce muta-
tions into the seed region of the 1st and 2nd miR-15/16 target sites, respectively
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(TGCTGCTA>AGCAGGTA). For the construct containing mutations in both miR target
sites, the primer pairs were used sequentially. Using LUC-MCS cycE1 WT and LUC-MCS
cycE1 CPE mut in these reactions produced miR mut and CPE+miR mut constructs. A Nhe I
restriction site was introduced immediately upstream of the BamH I site of LUC-MCS using
site-directed mutagenesis with primer pair Fluc Ccne1 Nhe mutF/ Fluc Ccne1 Nhe mutR.
For in vitro transcription, the plasmid was linearised with Nhe I (to obtain a poly(A)-
mRNA) and transcribed using T7 RNA Polymerase. For transcripts containing an (A)48 tail, a
silent mutation was introduced into the Fluc ORF to remove the EcoR I restriction site using
site-directed mutagenesis (primer pair Fluc EcoRI mutF / Fluc EcoRI mutR). These plasmids
were linearised with EcoR I and transcribed using T7 RNA polymerase to obtain poly(A)50
transcripts. The luc-400 plasmid (a gift from Dr Lucy Colegrove-Otero) was constructed to
contain the antisense sequence of the 290–712 fragment of cloning vector pSP6-T3.
For tethering assays, firefly luciferase mRNA transcribed from the lucMS2 plasmid was
used as an internal control. It was linearised with SpeI prior to transcription with T7 RNA
polymerase. For firefly luciferase reporter assays, the hRluc mRNA transcribed using T7 RNA
polymerase from the phRL-TK linearised with Not I was used as a control. In vitro poly(A) tail-
ing reactions were carried out as above.
For injection of competitor CPE-containing RNAs, the cyclin B1 3’UTR 65 bp fragment
(gauccuaaauaguguauuguguuuuuaauguuuuacugguuuuaauaaagcucauuuuaacaugg) was created
by annealing complementary primers JA14/15, which were then cloned into the EcoR I/BamH
I sites of the pGEM2 vector (Promega). The plasmid was linearized with EcoR I (to obtain a
poly(A)- transcript) and transcribed using T7 RNA Polymerase. The 3’UTR containing no
CPE sequences was derived from the 86 bp wee1 eCPE construct (uuuauugacuuuguuguuuuug
guaucuuauugucugguaaauaaaaauuggaaugugua), a gift from A. Charlesworth [44]. Introduction
of the eCPE mutation to obtain a sequence without CPEs was performed by mutagenesis using
primers JA31/32 (see S1 Table).
Xenopus oocyte and egg lysate preparation
Isolation, staging, handling, and lysate preparation of Xenopus oocytes and eggs was performed
as previously described [5]. Defoliculated stage VI oocytes were meiotically matured to eggs
with the addition of 10 μg/ml progesterone for 20 h or as indicated.
Luciferase assays
Stage VI oocytes were injected with 0.2 fmol of each of in vitro transcribed FLuc reporters and
RLuc control mRNAs, and, unless indicated otherwise, the oocytes were incubated for 6 h.
5 pools of 5 oocytes were collected and lysed using 200 μl 1 x PLB (Passive Lysis Buffer, Pro-
mega). Luciferase activities were determined with the Dual Luciferase system (Promega) using
a Glomax luminometer, as described previously [45]. For tether function assays, 40 fmol of
mRNA encoding the λN fusion protein were injected. Fluc control were coinjected. Oocytes
were incubated for 6h, lysed and assayed for luciferase expression.
miRNA inhibitors
LNA inhibitors targeting xtr-miR-16a and -15b (miRCURY LNA Knockdown 173011–00,
173013–00) as well as the miRNA Inhibitor Negative Control A were obtained from Exiqon.
For injections, 70 fmol of the miR-16a LNA and 700 fmol of the miR-15b and control LNAs
were injected into stage VI oocytes. Optimal concentrations of LNAs were empirically defined
by RT-qPCR, as those resulting in near-zero free targeted miRNA and unaffected levels of sev-
eral unrelated or even partly-homologous miRNAs (data not shown).
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Western Blotting
Western blotting was performed as described before [5] on 10% and 15% SDS-PAGE gels. Pri-
mary antibodies used: CPEB (1:2000; [46]), cyclin E1 (1:1000; gift of Tim Hunt) and HA
(1:1000; Roche).
Immunoprecipitation
Fifty nl of 50 ng/μl of the xtAgo2-HA polyA+ RNA were injected into stage VI Xenopus laevis
oocytes.25 oocytes were used per condition (-progesterone/+ progesterone). Anti-HA-biotin
antibodies (Roche) were bound to Dynabeads M-280 streptavidin (Invitrogen) and incubated
with oocyte lysates prepared in 150 mMNaCl, 25 mM Tris-HCl pH 7.4, 5 mM EDTA, 0.5%
NP40, 5 mMDTT, 1 mM PMSF, 50 μM leupeptin, 50 μM pepstatin, 0.5 μM aprotinin for 2h at
4°C. After washing, bound proteins were eluted with SDS sample buffer, and analysed by west-
ern blotting. For immunoprecipitation in the presence of RNAse A, stage VI Xenopus laevis
oocytes were injected with 46 nl of 500 ng/μl hAgo2-FLAG polyA+ RNA. After 24h 80 oocytes
per condition were lysed in NET buffer containing 20 pg/μl RNAse A. Lysate was incubated
with 80 μl of FLAG-M2 magnetic beads (Sigma) for 2h 30min at 4°C. After washing, bound
proteins were eluted with SDS sample buffer, and analysed by western blotting.
For immunoprecipitation of CPEB followed by RNA extraction, 5 μl CPEB antibody or an
isotype matched His-tag antibody (Abcam) was pre-bound to 25 μl protein A Sepharose beads
(GE Healthcare) equilibrated in 0.5 ml NET buffer supplemented with 1 mM DTT, 80 μ/ml
RNAse inhibitor for 4.5 hours at 4°C with agitation. Beads were washed twice with NET buffer.
Lysate of 500 oocytes was pre-cleared using 25 μl protein A Sepharose beads at 4°C for 1 h with
agitation in NET buffer. Pre-cleared lysate was added to antibody-bound beads and incubated
at 4°C for 2.5 h with agitation in 1 ml NET buffer. Beads were washed 3 times in NET buffer.
RNA was extracted from bound beads resuspended in 250 μl of TNES (0.1 M Tris, pH 7.5,
0.3 M NaCl, 5 mM EDTA, 2% SDS) with the addition of 200 μg/ml proteinase K at 50°C for
30 min with intermittent vortexing. RNA was purified by phenol/chloroform extraction followed
by ethanol precipitation in the presence of glycogen and was resuspended in H2O. For the
FLAG-Xp54, injections and immunoprecipitations were performed as described before [47].
RNA extraction from oocytes
Pools of 10 oocytes were lysed in 200 μl of TNES buffer (0.1 M Tris, pH 7.5, 0.3 M NaCl, 5 mM
EDTA, 2% SDS) with the addition of 200 μg/ml proteinase K. Lysates were cleared by spinning
at 12 krpm for 10 min. and incubated at 50°C for 30 min. RNA was extracted twice with acid
phenol (Ambion) and once with chloroform, and then precipitated by the addition of 3 vol-
umes of ethanol and incubation at -20°C overnight.
Real-time quantitative RT-PCR
Two μg of total RNA in 11 μl of aqueous solution was denatured for 10 minutes at 65°C. The
tubes were cooled on ice. 8 μl of master mix containing 1μl 10mM dNTPs, 1μl of each 10 mM
primer (3 per reaction) and 4 μl of AMV 5x buffer (Promega) was added to each sample. The
mixes were incubated at 42°C for 5 minutes. 1 μl of AMV-RT (Promega) was added to each
RT+ sample and the samples were incubated at 42°C for 90 minutes. Finally, the reactions were
denatured at 65°C for 10 minutes. The volume of the reaction was increased to 100 μl. 2 μl of
each reaction were used for the quantitative PCR reaction using Sybr Green JumpStart Taq
ReadyMix (Sigma) and 0.5 mM primers. The reaction was performed on a Rotor-Gene 6000
(Corbett), using primer pairs specified in the S1 Table.
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For small RNA quantitation in oocytes and CPEB RNA-IP, miR-15b and -16a were ampli-
fied using q-RTPCR as previously described [48], with the exception that total RNA extracted
from staged oocytes was used in the assay rather than a small RNA fraction. To ensure that the
RT reactions were biochemically as similar as possible, 150–300 ng RNA extracted from input
oocyte lysate or the indicated immunoprecipitates (irrespective of the number of oocytes the
RNA represented) were polyadenylated and reverse-transcribed primed with GCGAGCACA
GAATTAATACGACTCACTATAGGTTTTTTTTTTTTVN. To ensure accuracy and specific-
ity of measurement, and in compliance with miQE guidelines [49], the following controls were
included alongside experimental samples: 2-fold lower and higher dilutions of the input RNA
to demonstrate a dynamic response of the RT; a serial 5-fold dilution curve of a single RT reac-
tion for determination of relative quantities OR a serial dilution of synthetic miRNA mimics
(Qiagen) for determination of absolute quantities; a PAP-free reaction (PAP-) to insure that
small RNA amplification arose from non-adenylated RNA species; an RT-free reaction (RT-)
to account for RNA-independent non-specific amplification; template-free polyadenylation
(PAP0), template-free RT (RT0) and template-free PCR (NTC) reactions to eliminate reagent
contamination and dominant primer dimers. Real-time PCR using a universal reverse primer
and a specific forward primer was carried out in triplicate, and end products were analyzed by
an automated thermal dissociation curve to assure a single amplified product. For quantitation
in RNA-IPs, quantity (arbitrary units; a.u.) was derived using the included reference dilution
series. Outlying triplicates were manually removed, averages calculated, and the mean back-
ground signal obtained in PAP-, RT-, PAP0 and RT0 negative controls (typically<10% of
sample signal) was subtracted from the sample averages. The resulting quantity was then
divided by the number of oocytes represented by the RNA (a.u./oocyte). Enrichment was calcu-
lated by dividing each a.u./oocyte value obtained for immunoprecipitates by the value from the
matched input RNA.
Primer sequences for miRNAs and small RNA controls are listed in the S1 Table. The
maternal Xenopus laevis piRNA (piRNA-XL-MT3744) was described in [24].
Polyadenylation assays
8–10 microinjected oocytes/eggs (4000 cpm/oocyte) were resuspended in 20–50 μl per oocyte
TNES (0.1 M Tris-HCl pH 7.5, 0.3 MNaCl, 5 mM EDTA, 2%SDS) with 1.2 mg/ml proteinase K.
Crushed oocytes were incubated with intermittent vortexing at 50°C for 30 min, and the superna-
tant was phenol/chloroform extracted before EtOH precipitation. The extracted RNA was resus-
pended in 10 μl formamide dye per oocyte and analysed in sequencing type gels. 5% acrylamide gels
were used for long (~200 nt) and 6% acrylamide for short (~90 nt) RNAs. The size of RNAs was
estimated by comparison with øX174Hae III cut DNA [32P]-labelled molecular weight markers.
cDNAs for polyadenylation assays were synthesized using RNA ligation-coupled PCR as
described previously [50]. Gene specific primers used: cyclin E1 GAATCTGGCATGAGTGT
TG; cyclin B5 GGTCTATGAACAAAATGCCTC; cyclin B1 GGAGATCTTGTTGGCACCA
TGTGCTTC. PCR products were resolved on 3% agarose gels which were stained with ethid-
ium bromide.
Results
Cyclin E1 expression is regulated during oogenesis and oocyte
maturation
Cyclin E1 plays a critical role in the final stages of meiosis II following hormone stimulation of
the oocyte [40, 41]. Early studies suggested that in Xenopus oocytes cyclin E1 is present at very
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low levels, which increase prior to meiosis II. The protein accumulates in the egg after GVBD
in a phosphorylated, inactive form [37]. Two alternatively spliced forms of cyclin E1 mRNA,
with the same open reading frame, were cloned from a Xenopus unfertilized egg cDNA library,
and cyclin E1b (hereafter simply cyclin E1) mRNA was shown by Northern blot analysis to be
the major cyclin E1 transcript in oocytes, eggs and early stage embryos [38].
We systematically assessed cyclin E1 mRNA and protein levels during oogenesis and meiotic
maturation. Using RT-qPCR we show that the mRNA levels of Xenopus cyclin E1 double from
stage I to VI of oogenesis relative to GAPDHmRNA, and then fall slightly after maturation (Fig
1A). In contrast, cyclin E1 protein is absent from oocytes, and becomes detectable only late in matu-
ration. Its expression is seen subsequent to GVBD, which occurred around 7 hours after progester-
one addition in this experiment, and after CPEB has been degraded (Fig 1B, upper two panels).
Hence, translation of stored maternal cyclin E mRNA is activated in meiotically-maturing eggs.
Next we assessed whether this control correlated with cytoplasmic polyadenylation. RNA analysed
from the samematuration time course revealed that activation of cyclin E synthesis was preceded
by polyadenylation of its mRNA (Fig 1B lower panel). Examination of the 3’UTR of Xenopus cyclin
E1 mRNA revealed several putative regulatory sequences, including canonical CPE sequences, three
in tandem and one that overlaps with the nuclear hexanucleotide AAUAAA, as well as one poten-
tial embryonic CPE (eCPE;>U11) [51], contiguous with the overlapping CPE (Fig 1C; S1 Fig).
Cyclin E1 mRNA is translationally regulated by CPE sequences in
oocytes and eggs
To determine whether the putative CPE sequences in the cyclin E1 3’UTR were functional in
oocytes, we constructed reporter plasmids containing firefly luciferase followed by either the
wild-type cyclin E1 3’UTR (WT), the cyclin E1 3’UTR containing mutations (UU->GG) in all
four of the CPE sequences (CPE mut) or a control 3’UTR of a similar length (400 nt) not con-
taining any known regulatory elements (luc400). The plasmids were linearised, in vitro tran-
scribed as capped but non-adenylated mRNAs and co-injected into oocytes together with an
internal control Renilla luciferase mRNA. RNA degradation is compromised in immature
oocytes, so such RNA is stable throughout the time of the experiment (see Introduction). Fol-
lowing an overnight incubation in the presence or absence of progesterone, reporter levels
were assessed. These revealed that the cyclin E1 3’UTR confers about 6-fold repression in the
oocyte compared to the control 3’UTR, and also that CPE sequences present in the cyclin E1
3’UTR are required for this repression, as mutation of these sequences resulted in a consider-
able albeit incomplete derepression of the reporter constructs (Fig 1D, oocyte).
Furthermore, maturation of oocytes into eggs resulted in a very robust activation (>40-fold)
of translation of the reporter construct containing the WT 3’UTR (Fig 1D, egg). This effect of the
WT 3’UTR can be viewed as comprised of the ~6-fold baseline repression of translation in
oocytes coupled with a ~7-fold activation of translation upon maturation. Both effects are largely,
but not completely, dependent upon intact CPEs. Moreover, as shown previously for cyclin B1
mRNA [52], mutation of the nearby nuclear hexanucleotide AAUAAA to AAGAAA also abro-
gates translational activation of cyclin E1 mRNA, even in the presence of all CPE elements (data
not shown). Thus cyclin E1 mRNA is translationally activated in a manner requiring CPE ele-
ments and the nuclear hexanucleotide, hallmarks of cytoplasmic polyadenylation.
Cyclin E1 mRNA is polyadenylated in the cytoplasm via CPE elements
during meiotic maturation
Polyadenylation of cyclin E1 mRNA was examined by microinjecting 32P-labelled 3’UTR tran-
scripts into the cytoplasm of oocytes, some of which were matured with progesterone. After an
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Fig 1. Translation of cyclin E1 during oocyte maturation is CPE-dependent. A. Cyclin E1 mRNA is present throughout oogenesis. RT-qPCRwas carried
out on total RNA extracted from staged oocytes and eggs. The graph represents the relative amount of cyclin E1 mRNA compared to GAPDHmRNA, with
values of each transcript set to 1 for stage I. Representative of 5 progesterone maturation experiments. B. Cyclin E1 protein is not expressed until late in
oocyte maturation following the polyadenylation of its mRNA. Stage VI oocytes were incubated with progesterone for the indicated times and the
corresponding lysates were analysed byWestern blot using cyclin E1 and CPEB antibodies (upper panels). RNA extracted from these oocytes was
subjected to RNA-ligation-coupled PCR poly(A) analysis (lower panel). *—non-specific band.C. The cyclin E1 3’UTR contains a cluster of three CPE
sequences and an additional one overlapping the hexanucleotide as well as two putative miR-15/16 target sites as indicated. Not to scale.D. CPE
sequences repress translation in immature oocytes, and activate translation in eggs. Schematic representation of reporters used. Firefly luciferase reporters
containing a control 3’UTR (luc400), the wild-type cyclin E1 3’UTR (WT) or the 3’UTR with mutations in the CPEs (CPE mut) were injected into stage VI
oocytes. Renilla luciferase reporter mRNA was co-injected as an internal control. Oocytes were incubated for 24h with or without progesterone and both sets
were assayed for luciferase expression. Firefly luciferase levels are expressed as a ratio to Renilla internal control. E. CPE sequences in the cyclin E1 3’UTR
direct polyadenylation during oocyte maturation. Radiolabelled RNAs representing theWT 3’-terminal 180 nt of the cyclin E1 3’UTR and the same fragment
with mutated CPE sequences were injected into oocytes, and maturation was induced by progesterone. RNA extracted from untreated oocytes and
progesterone-matured eggs was analysed by denaturing gel electrophoresis and autoradiography.
doi:10.1371/journal.pone.0146792.g001
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overnight incubation, total RNA from oocytes and eggs was isolated and analysed by denatur-
ing polyacrylamide gel electrophoresis, showing that the wild type cyclin E1 3’UTR RNA was
extended by some 170 nt following progesterone-stimulated maturation, but that no extension
was seen with cyclin E1 3’UTR RNA mutated in the CPE sequences (Fig 1E). Control experi-
ments using oligo(dT)-directed RNase H cleavage confirmed that the extension was indeed
due to polyadenylation (data not shown). We also showed, using immunoprecipitation of
lysate proteins UV-crosslinked with wild type and mutant 3’UTR RNAs, that CPEB binding to
cyclin E1 3’UTR requires the CPE elements (data not shown). Altogether we conclude that
cyclin E1 levels are dictated by 3’UTR CPE elements, which mediate repression in oocyte and
translational activation following CPEB-driven cytoplasmic polyadenylation during oocyte
maturation.
Cyclin E1 mRNA is a miR-15/16 target in the oocyte
Further examination of the Xenopus cyclin E1 3’UTR revealed, aside from the polyadenylation
elements, the presence of two miR-15/16 target sites characterized previously in mammalian
cyclin E1 mRNAs [33–36]. These sites are conserved in vertebrates, including zebrafish and
chicken (Figs 1C and 2A; S1 Fig), similarly to miR-15b and miR-16a. Overall, the 3’UTRs show
no stretch of conservation apart from the miRNA sites. Indeed, full seed sequence complemen-
tarity is maintained among vertebrate species and to a large extent within the remainder of the
mature miRNA (Fig 2B). Previously, we identified miRNAs 15a and 16b in Xenopus tropicalis
oocytes [22], in line with similar systematic deep sequencing studies in Xenopus laevis and tro-
picalis oocytes and eggs [24]. Here, quantitation of these microRNAs by real-time RT-PCR
analysis from staged Xenopus laevis oocytes revealed that mature species of both miRNAs are
detectable throughout oogenesis, with the levels of miR-15b significantly higher (0.1–1 fmol
per oocyte) than that of miR-16a (0.01–0.05 fmol per oocyte) (Fig 2B and 2C) as assessed by
quantitative PCR using miRNA mimics as reference.
To assess whether the RISC complex is functional in the Xenopus oocyte, we utilised λN/
box B constructs previously used in tethering assays in mammalian cell lines [53, 54]. In this
assay, a λN-tagged effector protein of the miRNA machinery (Ago2 or TNRC6) is tethered via
five Box B sites to the 3’UTR of a reporter mRNA, mimicking the action of a microRNA (see
Fig 3A). It is particularly appropriate in cells such as the non-dividing oocyte from which pro-
teins cannot be readily depleted (reviewed in [45]). We therefore compared the ability of Ago2
and GW182 to influence tethered Renilla luciferase reporter mRNA, alongside a control Firefly
luciferase mRNA, in transfected HeLa cells and in microinjected Xenopus oocytes. In the case
of GW182, we tethered the Δ1370 C-terminal effector domain of human TNRC6C [42], as this
is well-expressed in both cell types.
As previously reported in HeLa cells [42, 53, 54], λN-Ago2 and -GW182 reduce Rluc-levels,
but not Fluc protein levels, relative to proteins lacking the λN peptide, with the silencing
domain of GW182 being more effective than Ago2 (Fig 3A, left panel), likely due to its ability
to act downstream of Ago2. Interestingly, we found that GW182 was also more effective in
oocytes, compared to Ago2, though the proteins were equally well expressed (data not shown).
The degree of silencing was somewhat lower in oocytes relative to HeLa cells (Fig 3A, right
panel), reflecting, at least in part, that mRNA decapping is compromised in the oocyte (see
Introduction). Indeed, silencing in oocytes is entirely at the translational level, as shown by the
unchanging reporter mRNA levels determined by qRT-PCR (Fig 3B). Lower levels of required
components [55] could also contribute to the reduced silencing in oocytes. In addition, unlike
the mRNA expressed in HeLa cells, the mRNA injected into oocytes is typically capped but
non-adenylated, to reflect the state of maternal mRNAs. We found, however, that using poly
CPEB and miR-15/16 Regulate Cyclin E1 mRNA
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(A) polymerase to add a poly(A) tail to the tethering mRNAs did not affect the extent of silenc-
ing in oocytes (Fig 3B).
Next, to test whether the miR-15/16 target sites were active in the oocyte, we created firefly
luciferase-cyclin E1 3’UTR constructs containing single mutations in each of the sites (miR
mut1 and miR mut2, respectively) and mutations in both sites (miR mut), and compared them
with the reporter bearing the wild type cyclin E1 3’UTR. Reporter mRNAs and control Renilla
luciferase mRNA were injected into immature stage VI oocytes as before, and their expression
assayed after 6 h. These experiments showed that the miRNA target sites contribute to the
translational repression of cyclin E1 mRNA, and that the combined effect of mutating both
sites is additive, resulting in approximately 1.5–2 fold increase in translation (Fig 3C).
To validate further the cyclin E1 mRNAmicroRNA target sites, we pre-injected stage VI
oocytes with either a control LNA oligonucleotide or a mix of anti-miR-15 and -miR-16 inhibi-
tor LNAs. Luciferase activity levels were assayed after subsequent reporter injection and incu-
bation. These revealed that mutation of the miRNA target sites resulted in a 2-fold de-
repression of the reporter in the presence of the control non-target LNA oligo (Fig 3D, protein
level panel). Importantly, the pre-injection of specific anti-miR-15 and–miR-16 LNA inhibitors
resulted in the de-repression of the WT reporter, while the mutant mRNA was not significantly
affected. Furthermore, we demonstrated that RNA levels were unchanged (Fig 3D, RNA levels
panel). In conclusion, the effect of mutating the miR-15/16 sites and/or inhibiting endogenous
miR-15/16 using LNAs occurs largely on the translational level.
Fig 2. Mature forms of miR-15 andmiR-16 are present in Xenopus oocytes. A. Alignment of putative miR-15/16 seed binding sites across vertebrate
cyclin E1 3’UTRs. B. Alignment of vertebrate miR-15b and miR-16a reveals nearly perfect conservation of the two miRNAs, with the seed sequence
highlighted in bold.C. miR-15b and 16a levels do not undergo significant changes during oogenesis and oocyte maturation. Levels of the two microRNAs
were verified by qPCR alongside the control U2 snRNA. The graph represents absolute quantities throughout oogenesis in three independent biological
samples.
doi:10.1371/journal.pone.0146792.g002
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CPEB complexes are associated with miRISC
The experiments described above established that introduction of miR site mutations in the
context of the WT cyclin E1 3’UTR (i.e. in the presence of CPEs and therefore presumably in
association with CPEB) resulted in a partial derepression of the reporter mRNA (Fig 3).
Fig 3. ThemiRISC as well as the putative miR-15/16 target sites in the cyclin E1 3’UTR are functional. A. Tethering of either Ago2 or the effector
domain of GW182 represses translation of a reporter in mammalian cells as well as in Xenopus oocytes. Schematic representation of reporters used. mRNAs
encoding lambda-N peptide with an HA-tag or an HA-tag only, fused to GW182 effector domain or Ago2 were either injected into oocytes for 24 h prior to
injection of Renilla luciferase reporter mRNA containing 3’UTR Box B sites (Rluc-BoxB) or transfected into HeLa cells 24 h prior to transfection of plasmids
encoding the reporter genes. An mRNA/plasmid encoding Firefly luciferase was co-injected/co-transfected as an internal control. After a 6 h incubation, cells
were harvested and reporter protein expression was assessed. The experiment was repeated 3 times with similar results. B. Repression of a reporter mRNA
tethered to the effector domain of GW182 is independent of a poly(A) tail. Schematic representation of reporters used. The experiment was performed in
Xenopus oocytes as in A, using either non-adenylated (pA-) or in vitro polyadenylated (pA+) RNA. RNA was assessed from a pool of 50 injected oocytes.C.
The two miR-15/16 sites co-operate in repressing translation of the cyclin E1 3’UTR. Luciferase reporters containing the wild-type cyclin E1 3’UTR (WT),
mutations in the first miR target site (miR mut1), the second target site (miR mut2) or both (miR mut) were injected into stage VI oocytes. Renilla luciferase
mRNA was co-injected as an internal control. Firefly luciferase levels are expressed as a ratio to Renilla internal control. The graph displays the results for a
representative experiment.D. The miR-15/16 target sites are active in a degradation-independent manner. Luciferase reporters containing the wild-type
cyclin E1 3’UTR (WT) or the cyclin E1 miR mut 3’UTR were injected into oocytes (see C for further details), in the presence of co-injected control or miR-15/
16 LNAs, as indicated. * Student t-test P<0.01. RNA extracted from injected oocytes was subjected to reverse transcription and quantitative real-time PCR to
assess RNA levels, which are expressed as a ratio of firefly to Renilla luciferase. The graph displays the results for a representative experiment.
doi:10.1371/journal.pone.0146792.g003
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Previously, we showed that CPEB is found in a very large RNP complex in oocytes, and
mRNAs and partner proteins, including cyclin B1 mRNA and Xp54/DDX6 RNA helicase, can
be readily co-immunoprecipitated with CPEB antibodies [5].
To address whether the RISC complex interacts with CPEB, indicating a potential combined
mode of translational control, we injected mRNAs encoding HA-tagged Xenopus tropicalis
Ago2 protein into stage VI oocytes, subsequently incubated with and without progesterone.
Immunoprecipitation using an anti-HA antibody revealed that endogenous CPEB co-immu-
noprecipitates with HA-Ago2 in oocytes (but not in eggs when CPEB is degraded), suggesting
an interaction between the miRNA machinery and the CPEB RNP (Fig 4A). We were able to
demonstrate that this association is RNA-independent in immunoprecipitations performed in
the presence of RNAse (S2 Fig).
Next, we assessed the presence of miRNAs in association with the CPEB complex. Immuno-
precipitation was performed with stage VI oocyte lysates prepared from 2 different frogs, using
a monoclonal anti-CPEB antibody [5] and an unrelated isotype-matched control antibody
(anti-His). Bound RNA was extracted and analysed by real time RT-PCR to reveal that both
miR-15b and -16a, but not a piRNA (pi3744; [24]) of similar length and abundance as miR-
15b, are specifically co-precipitated with CPEB. Moreover, the abundant 5S rRNA, U1b or U2
snRNAs were also not co-precipitated with CPEB. A similar specific enrichment was measured
in anti-FLAG immunoprecipitates of oocytes injected with mRNA encoding FLAG-tagged
Xp54/DDX6, CPEB’s interacting partner [56], but not of uninjected oocytes (Fig 4B). Alto-
gether we conclude that CPEB interacts with Ago2 and microRNAs. The coordinated regula-
tion resulting from co-residence of miRISC and other complexes involved in translational
regulation, such as the CPEB RNP complex, is an intriguing concept, adding an additional
level to the complexity of post-transcriptional regulation [57].
Fig 4. CPEB complexes andmiRISC cooperate in the regulation of translational activation of cyclin E1 during oocyte maturation. A. Components of
the RISC complex can associate with the translational silencing complex in immature oocytes (-p). Oocytes were injected with HA-Ago2 mRNA, and the
resulting lysates were subjected to immunoprecipitation with anti-HA antibodies. Input represents 5% of the immunoprecipitated fractions. Western blotting
was performed with anti-HA or -CPEB1 antibodies and visualised by ECL.–p–no progesterone, immature oocytes; +p–oocytes matured with progesterone.
B. miRNAs co-immunoprecipitate with CPEB complexes. Lysates from uninjected oocytes or oocytes expressing a FLAG-tagged Xp54 were used for
immunoprecipitation using a monoclonal anti-CPEB antibody, an isotype-matched control (His), or in the case of FLAG-Xp54 expressing oocytes and
uninjected control (“-“), an anti-FLAG antibody (FLAG). RNA was isolated and real-time RT-PCR performed for the miRNAs and small RNAs indicated.
Relative quantities were normalised per oocyte input. For plotting purposes all enrichment values were scaled to the enrichment of miR-15 in the CPEB
immunoprecipitate of Experiment 2.
doi:10.1371/journal.pone.0146792.g004
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Inhibition of miR-15/16 causes premature polyadenylation of cyclin E1
mRNA and acceleration of meiotic maturation
The critical aspect of CPEB activity is the precisely-timed relief of repression and subsequent
activation of translation of its target mRNAs during oocyte maturation, prior to its proteolysis.
A previous study developed a method to show these two functions in greater temporal resolu-
tion, by the injection of short CPE-containing RNA that acts as a competitor for CPEB protein,
which first triggers the derepression of endogenous CPE-containing mRNAs followed later by
polyadenylation-mediated activation [2]. We injected the CPE-containing fragment of the
cyclin B1 3’UTR or a control RNA of similar length. Following an overnight incubation,
oocytes were injected with WT or miR mut reporter constructs and incubated as for other
reporter experiments. As expected, the translation of reporter mRNA with CPE elements was
derepressed (approximately 3-4-fold) by prior injection of short CPE RNA relative to control
RNA, demonstrating that competing CPEB off the target mRNA was effectively mimicking
early maturation events. Interestingly, we observed a statistically significant increase in the
extent of derepression of the miR mut construct in oocytes with limiting CPEB levels (pre-
injected with CPE-RNA) compared to control oocytes (pre-injected with control RNA) (Fig
5A). These results suggest that while in immature oocytes, miRISC requires CPEB to act upon
the cyclin E1 mRNA, in an environment in which CPEB is being competed off the CPE-con-
taining mRNAs, miRISC reinforces the interaction of CPEB with the same mRNA. It is tempt-
ing to speculate that the co-occupancy of the two complexes on the mRNA serves to stabilise
each other when in close proximity.
To test this possibility, we examined the role of this regulation in the activation of cyclin E1
mRNA during oocyte maturation. Since we have shown that this activation is preceded and
driven by the polyadenylation of the mRNA (Fig 1), we analysed the poly(A) status of endoge-
nous cyclin E1 mRNA during a time course following injection of specific LNA oligos inhibi-
tory to miR-15 and -16, or control LNAs (validated in Fig 3D), or in uninjected oocytes (Fig
5B). Oocytes were incubated overnight, and then subjected to progesterone treatment. Samples
were taken at indicated time points and extracted RNA was subjected to the RNA ligation-
linked poly(A) assay [50]. We observed that in oocytes injected with the anti-miR-15/16 LNAs,
an initial limited polyadenylation of cyclin E1 mRNA was observed at 6 h, which for the unin-
jected and control LNA injected oocytes did not occur until 7.5 h. In contrast, there was no
change in the timing of polyadenylation of cyclin B1 or B5 mRNAs, which have no miR-15/16
sites in their 3’UTRs, suggesting that the inhibition of miR-15/16 specifically prematurely acti-
vates cyclin E1 mRNA polyadenylation.
Finally, determining the GVBD timing during a maturation time course in five experiments
revealed that injection of anti-miR-15/16 LNAs accelerates maturation of oocytes when com-
pared to injection of control LNA (Fig 5C), presumably as a result of the early polyadenylation
and translational activation of cyclin E1 and potentially other target mRNA when miR-15/16
levels are reduced (Fig 5B).
On the basis of the reporter mRNA analyses and the oocyte experiments, we conclude that
miR-15/16 and CPEB co-regulate cyclin E1 mRNA. Moreover, inhibition of miR-15/16 in the
immature oocyte results in accelerated meiotic maturation reinforcing the notion of these miR-
NAs playing major roles as cell cycle regulators. To our knowledge this is the first demonstra-
tion of microRNAs regulating the timing of mRNA polyadenylation.
Discussion
We report that the translation of cyclin E1 mRNA is tightly regulated in the Xenopus oocyte
and egg by its 3’UTR CPE elements, and two neighbouring conserved miR-15/16 sites. The
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CPE elements and the miRNA binding sites repress translation in the oocyte and during mei-
otic maturation, and CPE elements promote cytoplasmic polyadenylation and translational
activation in the egg. Tight regulation of cyclin E1 levels presumably reflects its important roles
Fig 5. Inhibition of miR-15/16 causes premature polyadenylation of cyclin E1 mRNA and acceleration of meiotic maturation. A. Injection of a molar
excess of CPE-containing RNA competitor enhances the effect of miR site mutations. 500 fmol of either a control 85 nt RNA not containing any CPE
sequences (no CPE UTR) or a 65 nt 3’–terminal sequence of the cyclin B1 3’UTR (cyclin B1 UTR) were injected into stage VI oocytes. After an overnight
incubation, oocytes were re-injected with either the WT or miR mut Firefly reporter constructs and the Renilla control RNA. The oocytes were lysed and
assayed for luciferase after 6 h. The graph represents and average of 3 experiments with theWT reporter normalised to 1 in each case. (** P<0.01, 2-tailed
paired t-test).B. Uninjected stage VI oocytes (u.i) or oocytes injected with control LNA (ctrl LNA) or a mixture of anti-miR-15 and anti-miR-16 LNAs (15+16
LNA) were incubated overnight, following which they were stimulated with progesterone. Samples were taken at indicated times. Extracted RNA was
subjected to RNA-ligation coupled PCR polyadenylation analysis using primers for indicated mRNAs. Vertical red line indicates early polyadenylation in 15
+16 LNA injected sample. Panel shows a representative experiment of 4. Graph underneath cyclin E panel depicts ImageJ profile plot taken along the dotted
line. C. 100–150 stage VI oocytes were injected with either control LNA (ctrl LNA) or anti-miR-15 and anti-miR-16 LNAs (15+16 LNA) and incubated overnight
and then treated with progesterone. GVBD was scored by the appearance of a white spot on the animal pole of the oocyte. The time required for 50% of the
oocytes to achieve GVBD (GVBD-50) is plotted for 5 independent experiments.
doi:10.1371/journal.pone.0146792.g005
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in cell cycle progression as it is required for metaphase II arrest in the egg as well as S-phase ini-
tiation in the early embryo [40, 41].
Reflecting our interest in the cytoplasmic control of cyclin E1 mRNA poly(A) tail length
and translation, our analysis was based on the microinjection of mRNAs (and LNA antago-
mirs) into the cytoplasm of defolliculated stage VI oocytes, which can meiotically mature in
response to progesterone. It is interesting to note that a study using folliculated stage IV-VI
Xenopus oocytes and relying on nuclear co-injection of reporter mRNA and microRNA con-
cluded that microRNAs activate translation [58].
Dual regulation of translation by CPE elements is a well-known mechanism to control pro-
tein levels during oogenesis and meiotic maturation, and the extensively characterised exam-
ples include members of the Xenopus cyclin B mRNAs [11]. Indeed, the number and relative
location of the CPE elements in the cyclin E1 3’UTR conform very well to the rules obtained in
this landmark paper on the combinatorial code for cytoplasmic polyadenylation elements. For
an mRNA to be repressed in the oocyte requires a cluster of at least two CPEs, optimally sepa-
rated by 10–12 nt, while cytoplasmic polyadenylation in the maturing egg following progester-
one stimulation requires at least one CPE located less than 100 nucleotides from the nuclear
hexanucleotide signal, and late polyadenylation (at or after GVBD) is directed by a CPE ele-
ment overlapping the hexanucleotide. As previously reported, the putative eCPE (>U11, [51],
the hexanucleotide and an upstream AU-rich element (very likely corresponding to our cluster
of three CPEs) promote polyadenylation of cyclin E1 mRNA later in development, during
Xenopus embryogenesis [59].
Comparison of cyclin E1 3’UTRs in Xenopus, zebrafish, mouse and man (S1 Fig) revealed
that consensus CPEs (U4A1-2U) characterised experimentally here in Xenopus are not well con-
served in mammals. Indeed, human and mouse cyclin E1 appear to have only the CPE element
that overlaps the hexanucleotide, though possibly non-consensus CPEs, UA-rich elements
comprising at least four U bases, may operate here. Alternatively, the rules obtained for matur-
ing Xenopus oocytes [11] may not readily transfer to other organisms. Indeed it has been noted
that in the case of the cyclin B1 3’UTR, zebrafish diverges from Xenopus, with the positions
and sequences of the functionally defined CPEs being poorly conserved [60]. In the case of the
cyclin E1 3’UTR, the upstream CPE elements are present in zebrafish, but the overlapping one
is absent, though an additional potential D. rerio CPE element is found downstream of the hex-
anucleotide (S1 Fig), in a similar configuration to that observed in its cyclin B1 mRNA [60].
In contrast, both cyclin E1 miR-15/16 binding sites are highly conserved from frog to man,
one site just upstream (~10–25 nt) of the hexanucleotide, with the second one located ~ 250
nucleotides upstream (S1 Fig). Using microinjected reporter-cyclin 3‘UTR mRNAs with wild
type or mutated miRNA binding sites, we showed that each functioned to moderately repress
translation in the oocyte, with an additive effect being observed when both sites were mutated;
in agreement with studies in mammalian cells [33, 35, 36]. Furthermore, we showed that miR-
NAs repress translation in the oocyte, with no significant effects on reporter mRNA levels.
Similarly, in tether function assays we noted that the effector domain of GW182 represses
bound mRNA, rather than destabilising it. Moreover, no additional repression was observed
when a poly(A) tail was added to the reporter mRNA prior to injection. In several studies, a
poly(A) tail was noted to enhance but not be required for microRNA silencing ([61] and refer-
ences therein) possibly due to enhanced decay. Indeed, the effector domain of GW182 interacts
with components of the CCR4–NOT and PAN2/PAN3 deadenylase complexes as well as
PABP, resulting in target mRNA deadenylation, and ultimately decay [62–64]. Interestingly,
deadenylases also exert translational repression, mediated by the recruitment of DDX6 by
CNOT1 [65–67].
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As discussed in the Introduction, mouse maternal miRNAs do not appear to be essential for
proper development, though reporter studies indicate they may play a role in regulating expres-
sion of target mRNAs, depending on the identity and/or number of microRNA-binding sites
[25–28]. We provide evidence in this study of a contributing role of microRNAs in silencing a
CPE-target mRNA in Xenopus oocytes and eggs. Such a role may be more important in Xeno-
pus development as mouse maternal mRNA is degraded at the 2 cell-stage in contrast to the
Fig 6. Schematic summary of results andmodel of action of CPE- andmicroRNA-binding sites in cyclin E1mRNA duringmeiotic maturation. In the
immature oocyte, the presence of CPE sequences on maternal mRNAs stabilises the association of miRISC with the target mRNA to cause augmented
translational repression (WT vs. miR mut). In the absence of either the CPE sequence alone or both CPEs and miRNA target sites, the mRNA cannot bind
the CPEB RNP nor RISC and is therefore not repressed. In the presence of RNAs competing for CPEB, miRISC acts to reinforce the interaction of the limited
CPEB protein with the mRNA resulting in lower translation rates compared to the miR mut mRNA which does not bind miRISC. During GVBD, when the
degradation of CPEB begins, once again, co-association of CPEB and miRISC with an mRNA stabilises both interactions and delays polyadenylation and
translational activation. Mutation of the miRNA target sites or inhibition of miR-15/16 allows for early polyadenylation and activation of the transcript. In our
model, we have not distinguished the functionally similar but temporally distinct roles of CPEB1 and CPEB4 [72].
doi:10.1371/journal.pone.0146792.g006
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~4096 cell stage during Xenopus embyogenesis, at the mid-blastula transition, when zygotic
transcription is initiated. Interestingly, the rapid deadenylation and clearance of maternal
mRNAs is mediated by a conserved microRNA, miR-430 in zebrafish and miR-427 in Xenopus
embryos, synthesised after fertilisation [68, 69].
The focus of our work was cyclin E1 mRNA whose expression during oogenesis and meiotic
maturation is tightly regulated by 3’UTR CPE elements, and by two miR-15/16 binding sites
(summarised in Fig 6). Our results provide evidence of how miRNAs may function to add an
additional level of control over major regulatory mechanisms such as CPEs/CPEB. While the
miRNA sites are not absolutely required for either the repression or activation of cyclin E1
mRNA, they provide kinetic fine-tuning in a process in which timing is critical. Inhibition of
miR-15/16 leads to the accelerated cytoplasmic polyadenylation of the cyclin E1 mRNA. Even
more strikingly, injection of anti-miR-15/16 LNAs resulted in a marked and significant acceler-
ation of GVBD compared to control sequences suggesting additional miR-15/16 targets in
addition to cyclin E1. In mammalian cells, the miR-16 family regulates cell cycle progression
and proliferation by regulating multiple cell cycle genes [33, 35, 70, 71].
We propose that CPEB facilitates the binding of miRISC to the mRNA containing both reg-
ulatory sequences (miRNA target site and CPE), which exerts additional repression in the
immature oocyte. The onset of maturation causes selective phosphorylation and degradation
of CPEB, but miRISC, which has already been put in place, delays the polyadenylation and also
potentially stabilises the association of the repressive form of CPEB on the mRNA, ultimately
resulting in the late activation of the mRNA. This would be consistent with the well described
activity of miRISC in promoting the deadenylation of target mRNAs.
There is mounting evidence for the existence of interplay between regulatory sequence ele-
ments within 3’UTRs. A bioinformatics study revealed that in experiments where miRNA
function is inhibited, upregulated mRNAs show both positive and negative correlations for cer-
tain RNA-binding proteins (RBP) target sequences, suggesting that some regulatory elements
cooperate, while others compete with miRNA target sites [73]. Interestingly, most cooperative
effects, resulting in the preferential destabilisation of the mRNA, have been seen between
miRNA target sites, AU-rich elements and/or CPEs [39, 74–76]. Indeed, we (this study) and
others [39] have shown that these three features are all involved in regulating Xenopus cyclin
E1 expression. Additional examples include Pumilio, an important RBP involved in control of
development and the cell cycle, which also cooperate with miRNAs to regulate target mRNAs
[77, 78]. Our results support the notion of such a mechanism being widespread. Moreover, we
provide the first evidence of miRNAs contributing to the regulation of the precise timing of
relief of translational repression. Such mechanisms could be of great importance not only in
early development but also in neuronal function where localisation and timing of translational
activation are critical.
Supporting Information
S1 Fig. Sequence alignment of the human, mouse, frog and zebrafish cyclin E1 3’UTRs
using ClustalW2. CPE sequences are in bold and italic (overlapping CPE), the nuclear hexanu-
cleotide is bold and blue, and the two miR-15/16 binding sites are coloured yellow. Accession
numbers as follows: Hs BC035498; Mm NM_007633; Xl3.1-IMAGE:6638064.5.5; Dr X83594.
(TIF)
S2 Fig. Interaction of CPEB and Ago2 in the Xenopus oocyte is RNA-independent. Oocytes
were injected with FLAG-Ago2 mRNA, and the resulting lysates were subjected to immuno-
precipitation with anti-FLAG magnetic beads in the presence of RNAse A. Input represents
10% of the immunoprecipitated fractions. Western blotting was performed with anti-FLAG or
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-CPEB1 antibodies. The arrow indicates the CPEB band.
(TIF)
S1 Table. Sequences of primer sequences used in this study.
(PDF)
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